×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Topic 2 Session 9 continued: Audits and Inspections in Pharmacovigilance – Industry Perspective
Speaker(s)
![Jonathan Rowell](/_Images/member/Generic_Image_Missing-Profile.jpg)
Audits and Inspections in Pharmacovigilance - Industry Perspective
Jonathan Rowell
Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom
Director Regulatory Compliance
Have an account?